Cargando…

Clinical Aspects and Current Therapeutic Approaches for FOP

Fibrodysplasia ossificans progressiva (FOP) is an extremely rare heritable disorder of connective tissues characterized by progressive heterotopic ossification in various skeletal sites. It is caused by gain-of-function mutations in the gene encoding activin A receptor type I (ACVR1)/activin-like ki...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kitoh, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555688/ https://www.ncbi.nlm.nih.gov/pubmed/32887348 http://dx.doi.org/10.3390/biomedicines8090325

Ejemplares similares

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

Clinical, evolution and therapeutical considerations upon a case of fibrodysplasia ossificans progressiva (FOP)
por: Rogoveanu, O, et al.
Publicado: (2013)

Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective
por: Pignolo, Robert J., et al.
Publicado: (2022)

FOP in South Africa: awareness leads to diagnosis
por: Scott, Christiaan
Publicado: (2011)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

FOP Is a Centriolar Satellite Protein Involved in Ciliogenesis
por: Lee, Joanna Y., et al.
Publicado: (2013)

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome
por: Pignolo, Robert J., et al.
Publicado: (2020)

Empfehlungen zur Versorgung von Patient:innen mit FOP
por: Seefried, L., et al.
Publicado: (2023)

International physician survey on management of FOP: a modified Delphi study
por: Di Rocco, Maja, et al.
Publicado: (2017)

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022)

Feline orofacial pain syndrome (FOPS): a retrospective study of 113 cases
por: Rusbridge, Clare, et al.
Publicado: (2010)

Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity
por: Lees-Shepard, John B, et al.
Publicado: (2018)

CEP19 cooperates with FOP and CEP350 to drive early steps in the ciliogenesis programme
por: Mojarad, Bahareh A., et al.
Publicado: (2017)

Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach
por: Tomaras, Stylianos, et al.
Publicado: (2021)

Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis
por: Kuchynka, Petr, et al.
Publicado: (2016)

Comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Pacifici, Maurizio, et al.
Publicado: (2019)

Structural and biophysical properties of FopA, a major outer membrane protein of Francisella tularensis
por: Nagaratnam, Nirupa, et al.
Publicado: (2022)

Front-of-pack (FOP) labelling systems to improve the quality of nutrition information to prevent obesity: NutrInform Battery vs Nutri-Score
por: Carruba, Michele O., et al.
Publicado: (2021)

FOP Negatively Regulates Ciliogenesis and Promotes Cell Cycle Re-entry by Facilitating Primary Cilia Disassembly
por: Jiang, Huadong, et al.
Publicado: (2020)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

Response to comment on 'Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity'
por: Goldhamer, David J, et al.
Publicado: (2019)

Application of in vitro Drug Metabolism Studies in Chemical Structure Optimization for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
por: Padilha, Elias C., et al.
Publicado: (2019)

A Randomized Controlled Study to Test Front-of-Pack (FOP) Nutrition Labels in the Kingdom of Saudi Arabia
por: Shin, Soye, et al.
Publicado: (2023)

Current aspects in sepsis approach. Turning things around
por: Candel, Francisco Javier, et al.
Publicado: (2018)

Gallstone Ileus–Clinical and therapeutic aspects
por: Beuran, M, et al.
Publicado: (2010)

Longitudinal Evaluation of Pain, Flare‐Up, and Emotional Health in Fibrodysplasia Ossificans Progressiva: Analyses of the International FOP Registry
por: Peng, Ke, et al.
Publicado: (2019)

ACVR1(R206H) FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification
por: Haupt, Julia, et al.
Publicado: (2019)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases
por: Baujat, Geneviève, et al.
Publicado: (2017)

Assessment of Nutritional Quality of Products Sold in University Vending Machines According to the Front-of-Pack (FoP) Guide
por: Lasala, Carmen, et al.
Publicado: (2022)

Vascular Aspects in Glaucoma: From Pathogenesis to Therapeutic Approaches
por: Mursch-Edlmayr, Anna-Sophie, et al.
Publicado: (2021)

Olmsted syndrome: clinical, molecular and therapeutic aspects
por: Duchatelet, Sabine, et al.
Publicado: (2015)

Myeloproliferative disorder FOP-FGFR1 fusion kinase recruits phosphoinositide-3 kinase and phospholipase Cγ at the centrosome
por: Lelièvre, Hélène, et al.
Publicado: (2008)

Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization
por: Pignolo, Robert J., et al.
Publicado: (2021)

Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs
por: Maekawa, Hirotsugu, et al.
Publicado: (2022)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

Validation of the Portuguese Version of the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) in Portuguese Cancer Survivors
por: Silva, Sandra, et al.
Publicado: (2022)

Current Therapeutic Approaches in FSHD
por: Wang, Leo H., et al.
Publicado: (2021)

Current trends in etiology, prognosis and therapeutic aspects of Parkinson’s disease: a review
por: Jagadeesan, A.J., et al.
Publicado: (2017)

Systemic Sclerosis: Current Concepts in Pathogenesis and Therapeutic Aspects of Dermatological Manifestations
por: Viswanath, Vishalakshi, et al.
Publicado: (2013)

Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
por: Nakase, Hiroshi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u7h848mlfk726odmfjmitjs1k4